The P makes the difference in plasma rich in growth factors (PRGF) technology.
Platelets (In press 2011)
Authors:
Anitua E, Sánchez M, Prado R, Orive G.
Authors:
Anitua E, Alkhraisat MH, Orive G.
Perspectives and challenges in regenerative medicine using Plasma Rich in Growth Factors.
Journal of Controlled Release (In Press 2011)
Authors:
Anitua E, Sánchez M, Orive G.
Potential of endogenous regenerative technology for in situ regenerative medicine.
Adv Drug Deliv Rev. 2010; 62 (7-8):741-52
Authors:
Sanchéz M, Anitua E, Andia I.
Poor standardization in platelet-rich therapies hampers advancement.
Arthroscopy, 2010, 26 (6), 725-6
Authors:
Orive G, Ali OA, Anitua E, Pedraz JL, Emerich DF.
Novel Biomaterial-based technologies for brain anti-cancer therapeutics.
Biochim Biophys Acta. 2010; 1806(1):96-107
Authors:
Anitua E, Sanchez M, Zalduendo M, de la Fuente M, Prado R, Orive G, Andía I.
Fibroblastic response to treatment with platelet rich preparations.
Cell Proliferation 2009; 42:162-170
Authors:
Anitua E, Sánchez M, Orive G, Andía I.
Shedding light in the controversial terminology for platelet rich products.
J Biomed Mater Res A 2009; 90 (4): 1262-3.
Authors:
Orive G, Anitua E, Pedraz JL, Emerich DF.
Biomaterials for promoting brain protection, repair and regeneration.
Nat Rev Neurosci. 2009; 10 (9): 682-92.
Authors:
Anitua E, Sánchez M, Orive G, Andía I.
Delivering growth factors for therapeutics.
Trends Pharmacol Sci 2008;29:37-41
Authors:
Nurden AT, Nurden P, Sánchez M, Andía I, Anitua E.
Platelets and wound healing.
Frontiers Biosci 2008; 13: 3532-3548.
Authors:
Anitua E, Sánchez M, Orive G, Andía I.
Potencial terapeútico de la tecnología del PRGF®.
Dental Dialogue 2008; 2:6-20.
Authors:
Anitua E, Sánchez M, Orive G, Andía I.
Desarrollo y aplicaciones terapéuticas de la tecnología del PRGF
Gaceta Dental, 2008; 196: 165-169.
Authors:
Anitua E, Sánchez M, Nurden AT, Zalduendo M, de la Fuente M, Azofra J, Andia I.
Reciprocal actions of platelet-secreted TGF-b1 on the production of VEGF and HGF by human tendon cells.
Plastic Reconstruct Surg 2007;119:950-959.
Authors:
Anitua E, Sánchez M, Orive G, Andía I.
The potential impact of the preparation rich in growth factors (PRGF) in different medical fields.
Biomaterials 2007; 28: 4551-4560.
Authors:
Anitua E.
Potencial terapéutico de la tecnología del PRGF®.
CIC Network 2007; 2:6062.
Authors:
Anitua E, Sánchez M, Nurden AT, Zalduendo M, de la Fuente M, Orive G, Azofra J, Andía I.
Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities.
J Biomed Mat Res A 2006;77:285-293
Authors:
Anitua E, Sánchez M, Nurden AT, Nurden P, Orive G, Andía I.
New insights into and novel applications for platelet-rich fibrin therapies.
Trends Biotechnology 2006;5:227-234.
Authors:
Anitua E, Sánchez M, Andía I, Orive G.
Plaketatik eratorritako sendagaia: aplikazio terapeutikoak.
Elhuyar 2005; 205:46-48.
Authors:
Anitua E, Andía I, Sánchez M, Azofra J, Zalduendo M, De la Fuente M, Nurden P, Nurden AT
Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture.
J Orthop Res 2005;23:281-286.
Authors:
Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT.
Autologous platelets as a source of proteins for healing and tissue regeneration.
Thromb Haemost 2004;91:4-15.
Authors:
Anitua E, Andía I, Sánchez M.
PRGF® (Plasma Rico en factores de crecimiento).
Dental Dialogue 2004; 3:6-19.
Authors:
Anitua E.
Pasmatische Wachstums-faktoren–eine therapeutische Revolution.
BDIZ Konkret 2002; 2:46-48.
Authors:
Anitua E, Bozzi L
Gel di Plasma Ricco di Piastrine.
Implantologia Orale 2001; 3:9-24.
Authors:
Anitua E.
Factores de Crecimiento plasmático. Una revolución terapéutica.
Ideas y Trabajos Odontoestomatológicos 2001; 2 (2):90-94.
Authors:
Anitua E, Sánchez M, Orive G.
The importance of understanding what is PRGF and what is not.
J Shoulder and Elbow Surgery 2011, 20, e23-e24